The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus (Q38451399)

3 September 2017

The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus (English)

1 reference

3 September 2017

Lina Wang

1

1 reference

3 September 2017

Juan C Felix

2

1 reference

3 September 2017

Joyce L Lee

3

1 reference

3 September 2017

Peik Y Tan

4

1 reference

3 September 2017

David E Tourgeman

5

1 reference

3 September 2017

Anne T O'Meara

6

1 reference

3 September 2017

Charles A Amezcua

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

3 September 2017

1 reference

3 September 2017

90

1 reference

3 September 2017

2

1 reference

3 September 2017

402-406

1 reference

The cell surface receptor encoded by the proto-oncogene KIT and its ligand

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

The protooncogene c-kit and c-kit ligand in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

The expression of c-kit protein in human adult and fetal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Expression of c-kit and kit ligand proteins in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Differential expression of the c-kit proto-oncogene in germ cell tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Chronic myeloid leukemia: current treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900274-9

7 January 2021

10.1016/S0090-8258(03)00274-9

Identifiers

DOI

1 reference

3 September 2017

1 reference